STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model
被引:18
作者:
Gao Lei
论文数: 0引用数: 0
h-index: 0
机构:
Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R ChinaSecond Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R China
Gao Lei
[1
]
Chen Li
论文数: 0引用数: 0
h-index: 0
机构:
Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R ChinaSecond Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R China
Chen Li
[1
]
Fei Xin-hong
论文数: 0引用数: 0
h-index: 0
机构:
Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R ChinaSecond Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R China
Fei Xin-hong
[1
]
Qiu Hui-ying
论文数: 0引用数: 0
h-index: 0
机构:
Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R ChinaSecond Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R China
Qiu Hui-ying
[1
]
Hong, Zhou
论文数: 0引用数: 0
h-index: 0
机构:
Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R ChinaSecond Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R China
Hong, Zhou
[1
]
Jian-min, Wang
论文数: 0引用数: 0
h-index: 0
机构:
Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R ChinaSecond Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R China
Jian-min, Wang
[1
]
机构:
[1] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai 200433, Peoples R China
K562;
cells;
leukemia;
multidrug-resistance;
imatinib mesylate;
xenograft model antitumor assays;
D O I:
10.1097/00029330-200606010-00006
中图分类号:
R5 [内科学];
学科分类号:
1002 [临床医学];
100201 [内科学];
摘要:
Background The development of the targeted signal transduction inhibitor STI571 has prompted us to treat chronic myeloid leukemia in different ways. Since STI571 may reverse multidrug-resistance of K562/MDR cells in vitro, we studied the effect of STI571 on multidrug-resistant K562 cells in vivo. Methods Multidrug-resistant human leukemia cell line K562-n/VCR expresses both bcr/abl fusion gene and multi-drug resistance (mdr1) gene. It is a vincristine resistant cell line subcloned from the vincristine (VCR) sensitive cell line K562-n induced by vincristine in vitro. K562-n and K562-n/VCR cells were inoculated subcutaneously into both sides of nude mice breast (5 x 10(6) cells/each) to establish a human leukemia xenograft model. The incidence and volume of tumor were observed. In the tumor-bearing nude mice, anti-tumor drugs vincristine, daunorubicin (DNR), STI571, and STI571 plus VCR for the treatment of mdr1 and bcr/abl double positive leukemia were studied respectively. Results The tumor incidence was 100% in the nude mice inoculated with either K562-n or K562-n/VCR. The transcription of the mdr1 gene and expression of P-gp were negative in K562-n cells but positive in K562-n/VCR cells. The intracellular accumulation of DNR in K562-n cells was higher than that in K562-n/VCR cells (P < 0.05). The tumor incidence of K562-n/VCR cells in nude mice was much higher than that of K562-n cells in chemotherapy groups, and the mean volume of the tumors was also larger (P < 0.05). STI571 combined with VCR significantly suppressed the proliferation of K562-n/VCR cells. Conclusions The MDR characteristics of K562-n/VCR in vivo were the same as in vitro. STI571 had a significant tumor-suppressing effect on VCR-sensitive leukemia cells and a moderate effect on MDR leukemia cells. VCR combined with STI571 had an excellent tumor-suppressing effect on both K562-n/VCR and K562-n in the human-nude mice xenograft model.